Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SYMONDS G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dolnikov, A; Millington, M; Beruter, E; Yi, SN; Symonds, G
      The beta-galactosidase gene as a marker for hematopoietic reconstitution: Individual cell analysis in a murine bone marrow transplantation model

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Dolnikov, A; Millington, M; Sun, LQ; Symonds, G
      Induced p21(WAF1) expression acts to reverse myc myelomonocytic cell transformation

      CANCER GENE THERAPY
    3. Wang, XH; Symonds, G
      Coastal embayment circulation due to atmospheric cooling

      JOURNAL OF GEOPHYSICAL RESEARCH-OCEANS
    4. Cooper, D; Penny, R; Symonds, G; Carr, A; Gerlach, W; Sun, LQ; Ely, J
      A marker study of therapeutically transduced CD4(+) peripheral blood lymphocytes in HIV discordant identical twins

      HUMAN GENE THERAPY
    5. Amado, RG; Mitsuyasu, RT; Symonds, G; Rosenblatt, JD; Zack, J; Sun, LO; Miller, M; Ely, J; Gerlach, W
      A phase I trial of autologous CD34(+) hematopoietic progenitor cells transduced with an anti-HIV ribozyme

      HUMAN GENE THERAPY
    6. Knop, AE; Arndt, AJ; Raponi, M; Boyd, MP; Ely, JA; Symonds, G
      Artificial capillary culture: expansion and retroviral transduction of CD4(+) T-lymphocytes for clinical application

      GENE THERAPY
    7. MacKenzie, KL; Dolnikov, A; Millington, M; Shounan, Y; Symonds, G
      Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice

      BLOOD
    8. WANG L; WITHERINGTON C; KING A; GERLACH WL; CARR A; PENNY R; COOPER D; SYMONDS G; SUN LQ
      PRECLINICAL CHARACTERIZATION OF AN ANTI-TAT RIBOZYME FOR THERAPEUTIC APPLICATION

      Human gene therapy
    9. AMADO RG; SYMONDS G; JAMIESON BD; ZHAO G; ROSENBLATT JD; ZACK JA
      EFFECTS OF MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR ON SURVIVAL AND RETROVIRAL TRANSDUCTION OF T-LYMPHOID PROGENITOR CELLS

      Human gene therapy
    10. DOLNIKOV A; SHOUNAN Y; MILLINGTON M; MACKENZIE K; SYMONDS G
      V-MYC IN A SIMPLE, SINGLE-GENE RETROVIRAL VECTOR CAUSES RAPID INDUCTION OF LEUKEMIA AND CONCOMITANT APOPTOSIS FOLLOWING BONE-MARROW TRANSPLANTATION

      Leukemia
    11. MACLEAN AL; SYMONDS G; WARD R
      IMMUNOLIPOSOMES AS TARGETED DELIVERY VEHICLES FOR CANCER THERAPEUTICS(REVIEW)

      International journal of oncology
    12. SYMONDS G
      TREATING SHOULDER COMPLAINTS IN GENERAL-PRACTICE - AUTHORS DIAGNOSTICSYSTEM IN UNCLEAR

      BMJ. British medical journal
    13. SHOUNAN Y; MACKENZIE K; DOLNIKOV A; MILLER M; SYMONDS G
      MYELOPROLIFERATIVE DISEASE AND MYELODYSPLASTIC SYNDROME INDUCED BY TRANSPLANTATION OF BONE-MARROW CELLS EXPRESSING MUTANT P53

      Leukemia
    14. LOWENSTEIN P; SYMONDS G
      INHIBITION OF MOLONEY MURINE LEUKEMIA-VIRUS BY A RETROVIRAL VECTOR, LNL6, CARRYING RIBOZYMES TARGETED TO THE 5'-NONCODING SEQUENCE

      Journal of General Virology
    15. SYMONDS G
      ROLE OF ANIMAL-EXPERIMENTS IN ASSESSING DRUG SAFETY NEEDS CLARIFICATION

      BMJ. British medical journal
    16. DOLNIKOV A; WARD RL; HAWKINS NJ; SYMONDS G
      APOPTOSIS IN V-MYC TRANSFORMATION OF MYELOMONOCYTIC CELLS AND ITS MODULATION BY CSF-1

      Oncogene
    17. DOLNIKOV A; KING A; LUXFORD C; SYMONDS G; SUN LQ
      RIBOZYME-MEDIATED SUPPRESSION OF V-MYC EXPRESSION ABROGATES APOPTOSISIN TRANSFORMED MONOCYTES

      Cancer gene therapy
    18. SHOUNAN Y; DOLNIKOV A; MACKENZIE KL; MILLER M; CHAN YY; SYMONDS G
      RETROVIRAL TRANSDUCTION OF HEMATOPOIETIC PROGENITOR CELLS WITH MUTANTP53 PROMOTES SURVIVAL AND PROLIFERATION, MODIFIES DIFFERENTIATION POTENTIAL AND INHIBITS APOPTOSIS

      Leukemia
    19. SYMONDS G; BLACK KP; YOUNG IR
      WAVE-DRIVEN FLOW OVER SHALLOW REEFS

      JOURNAL OF GEOPHYSICAL RESEARCH-OCEANS
    20. SMYTHE JA; SYMONDS G
      GENE THERAPEUTIC AGENTS - THE USE OF RIBOZYMES, ANTISENSE, AND RNA DECOYS FOR HIV-1 INFECTION

      Inflammation research
    21. DOLNIKOV A; SHOUNAN Y; HAWKINS NJ; WARD RL; SYMONDS G
      TRANSFORMATION BY V-ERB-B - INDUCTION OF APOPTOSIS IS ABROGATED IN A MYELOID CELL-LINE

      International journal of oncology
    22. SYMONDS G
      PAIN IN THE NECK, SHOULDER, AND ARM - TERMINOLOGY USED IS UNHELPFUL

      BMJ. British medical journal
    23. SUN LQ; SMYTHE J; PYATI J; GERLACH W; SYMONDS G
      RIBOZYME AND ANTISENSE CONSTRUCTS CONFER RESISTANCE TO HIV-1 INFECTION IN HEMATOPOIETIC-CELLS

      Journal of cellular biochemistry
    24. BLACK KP; GORMAN RM; SYMONDS G
      SEDIMENT TRANSPORT NEAR THE BREAK POINT ASSOCIATED WITH CROSS-SHORE GRADIENTS IN VERTICAL EDDY DIFFUSIVITY

      Coastal engineering
    25. SUN LQ; WANG L; GERLACH WL; SYMONDS G
      TARGET SEQUENCE-SPECIFIC INHIBITION OF HIV-1 REPLICATION BY RIBOZYMESDIRECTED TO TAT RNA

      Nucleic acids research
    26. SHOUNAN Y; MILLER M; SYMONDS G
      TRANSFORMATION OF FDC-P1 CELLS TO IL-3 INDEPENDENCE BY A RECOMBINANT MURINE RETROVIRUS CONTAINING V-ERB-B

      Experimental hematology
    27. SUN LQ; PYATI J; SMYTHE J; WANG L; MACPHERSON J; GERLACH W; SYMONDS G
      RESISTANCE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION CONFERREDBY TRANSDUCTION OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES WITH RIBOZYME, ANTISENSE, OR POLYMERIC TRANSACTIVATION RESPONSE ELEMENT CONSTRUCTS

      Proceedings of the National Academy of Sciences of the United Statesof America
    28. YI S; DOLNIKOV A; MACKENZIE KL; MILLER M; SYMONDS G
      MUTANT P53 TRANSFORMATION OF MURINE BONE-MARROW-DERIVED HEMATOPOIETIC-CELLS

      Blood
    29. SPILSBURY K; OMARA MA; WU WM; ROWE PB; SYMONDS G; TAKAYAMA Y
      ISOLATION OF A NOVEL MACROPHAGE-SPECIFIC GENE BY DIFFERENTIAL CDNA ANALYSIS

      Blood
    30. MILLER M; SYMONDS G
      A NOVEL V-ERB-B-TRANSFORMED CELL-LINE CO-EXPRESSING LYMPHOID AND MYELOID SURFACE-MARKERS

      International journal of oncology
    31. MACLEAN K; ROGAN EM; WHITAKER NJ; CHANG ACM; ROWE PB; DALLAPOZZA L; SYMONDS G; REDDEL RR
      IN-VITRO TRANSFORMATION OF LI-FRAUMENI SYNDROME FIBROBLASTS BY SV40 LARGE T-ANTIGEN MUTANTS

      Oncogene
    32. SYMONDS G; GARDINERGARDEN R
      COASTAL DENSITY CURRENTS FORCED BY COOLING EVENTS

      Continental shelf research
    33. SUN LQ; WARRILOW D; WANG L; WITHERINGTON C; MACPHERSON J; SYMONDS G
      RIBOZYME-MEDIATED SUPPRESSION OF MOLONEY MURINE LEUKEMIA-VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I REPLICATION IN PERMISSIVE CELL-LINES

      Proceedings of the National Academy of Sciences of the United Statesof America
    34. MACKENZIE KL; BONHAM L; SYMONDS G
      AN INTERNAL DELETION ENHANCES THE TRANSCRIPTIONAL ACTIVITY OF A RECOMBINANT RETROVIRUS IN HEMATOPOIETIC-CELLS IN-VIVO

      Journal of virology
    35. SYMONDS G
      DISEASE OF THE ROTATOR CUFF - ROTATOR CUFF SYNDROME DOES NOT EXIST

      BMJ. British medical journal
    36. MILLER M; SYMONDS G
      INDUCTION OF PRE-B LYMPHOID LEUKEMIA FOLLOWING RECONSTITUTION OF LETHALLY IRRADIATED MICE WITH V-ERB-B VIRUS-INFECTED BONE-MARROW PROGENITOR CELLS

      Journal of leukocyte biology
    37. MACKENZIE K; BONHAM L; SYMONDS G
      TRANSCRIPTIONAL ACTIVATION OF A RECOMBINANT RETROVIRUS

      Journal of leukocyte biology
    38. TOWNSEND M; MACPHERSON J; KRILIS S; REDDEL R; SYMONDS G
      IMMORTALIZATION AND CHARACTERIZATION OF HUMAN CELL-LINES WITH MAST-CELL AND MONOCYTIC PROPERTIES

      British Journal of Haematology
    39. HOLLOWAY PE; SYMONDS G; VAZ RN
      OBSERVATIONS OF CIRCULATION AND EXCHANGE PROCESSES IN JERVIS BAY, NEW-SOUTH-WALES

      Australian Journal of Marine and Freshwater Research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 12:19:01